Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Rhythm Pharmaceuticals Secures $150 Million in Convertible Preferred Stock Financing
-
Aemetis Implements Microsoft Dynamics(TM) ERP System to Support Current Operations and Expansion Projects
-
Lorenzo Protocol Announces Strategic Integration with Babylon to Revolutionize Bitcoin's Application Layer
-
ZimVie Announces Closing of Sale of Spine Business
-
ASP Isotopes Inc. Enters Into Purchase Agreement With a Leading Semiconductor Company for the Supply of Highly Enriched Electronic Gases
-
Nanox Announces Fourth Quarter of 2023 Financial Results and Provides Business Update
-
Biora Therapeutics Announces $6 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
-
AdTheorent Holding Company, Inc. Enters into Agreement to be Acquired by Cadent, LLC for Approximately $324 Million Representing $3.21 Per Share
-
Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech Executive
-
Milestone® Pharmaceuticals to Present Data on Etripamil at the American College of Cardiology and European Heart Rhythm Association Annual Conferences
-
Daxor Corporation to Exhibit at the American College of Cardiology for ACC.24
-
Disc Reports Topline Results from Phase 2 AURORA Study of Bitopertin in Patients with Erythropoietic Protoporphyria (EPP)
-
Soluna to Present at the AI & Technology Hybrid Investor Conference Presented by Water Tower Research on April 10
-
Eos Energy and Pine Gate Renewables Sign Agreement to Expand Existing Relationship
-
Lifecore Biomedical Provides Business Update Outlining Fiscal 2024 Outlook and Year-to-date Progress
-
AlphaGen Intelligence Corp. Announces Its Production of the World’s Largest Immersive Beauty Brand Platform, Built on top of Blockchain Technology
-
Kratos and Shield AI Conduct AI-Piloted Flights on the Kratos Tactical Firejet
-
Mullen Files for Foreign Trade Zone Status in Tunica, Mississippi
-
Corcept Completes Enrollment in Phase 3 Gradient Trial of Relacorilant in Patients With Adrenal Cushing’s Syndrome
-
FOR IMMEDIATE RELEASE: The Global FoodBanking Network Welcomes Vanessa Garcia as Chief Financial Officer
-
Verizon to award $50K disaster-preparedness grant to KIPP DC Public Schools during April 2 event
-
Annovis Announces Publication That Supports Understanding of Buntanetap’s Mechanism of Action in Humans
-
SLR Investment Corp. Schedules the Release of its Financial Results for the Quarter Ended March 31, 2024
-
aTyr Pharma to Participate in April Investor Conferences
-
Esperion to Ring Nasdaq Opening Bell Today, April 1, 2024
-
NewAmsterdam Pharma Announces the Appointment of Juliette Audet as Chief Business Officer
-
Smith+Nephew introduces the RENASYS™ EDGE Negative Pressure Wound Therapy System – an exciting new option in home-based care for patients living with chronic wounds
-
Vishay Intertechnology Announces 2024 Annual Meeting of Stockholders
-
NEXGEL Reports Full Year 2023 Revenue of $4.1 Million, an Increase of 99.7% Year-Over-Year
-
Vaultbit's Outlook for 2024: Comprehensive Entry into the Cryptocurrency Market and Preparation for Listing
-
Medigus Reaps Success with First Installation of a Wireless Charging System for Automatic Car Parks
-
Discovery Files NI 43-101 Technical Report for the Cordero Project Feasibility Study
-
Solid Biosciences Receives Rare Pediatric Disease Designation from the FDA for Duchenne Muscular Dystrophy Gene Therapy Candidate SGT-003
-
Glucose Health, Inc. Announces Expansion of Fiber Up® Brand – More Drink Mix Flavors and New Fiber Up® Gumdrops
-
Bombardier Announces April 3, 2024 as the Start of its New Normal Course Issuer Bid
-
BioRestorative Therapies Announces Filing of 2023 Annual Report on Form 10-K
-
Foundation for Sarcoidosis Research Launches Say Sarcoidosis Campaign to Shed Light on the 1.2 Million People Impacted by Sarcoidosis for April’s Awareness Month
-
Ebix Reports Conclusion of SEC Investigation and Dismissal of All Pending Securities Claims Against Ebix and its Officers in United States District Court for the Southern District of New York (SDNY)
-
GRI Bio Reports Full Year 2023 Financial Results and Provides Corporate Update
-
Vital Energy Announces Offering of $100.0 Million of Senior Notes
-
Cognition Therapeutics to host Virtual KOL Event on the Evolving Landscape in Alzheimer’s Disease on April 12, 2024
-
Evome Medical Technologies Punctuates Turn Around Plan with Strong Fourth Quarter Resulting in Positive Annual Adjusted EBITDA for Fiscal Year 2023
-
A. Duie Pyle Achieves Historic 100-Year Milestone
-
Watsco Boosts Annual Dividend 10% to $10.80 Per Share
-
Prenetics Announces Fourth Quarter and Full Year 2023 Financial Results
-
Context Therapeutics Submits IND Application to Evaluate CTIM-76 in Claudin 6-Positive Cancers
-
Fuse to Showcase Solutions for Networking the Battlespace at Sea-Air-Space 2024
-
Rakovina Therapeutics To Host Informational Webinar on April 3, 2024
-
Ocuphire Announces the U.S. Commercial Launch of RYZUMVl™ (Phentolamine Ophthalmic Solution 0.75%) by its Partner Viatris
-
Gilat Awarded Over $13M in Additional Orders from Satellite Operators for its World Leading SkyEdge IV and SkyEdge II-c Platforms
